Report Detail

Pharma & Healthcare Global Large Volume Parenteral (LVP) Market Insights, Forecast to 2025

  • RnM2306867
  • |
  • 02 August, 2019
  • |
  • Global
  • |
  • 124 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Global Large Volume Parenteral (LVP) Market Insights, Forecast to 2025

Table of Contents

    1 Study Coverage

    • 1.1 Large Volume Parenteral (LVP) Product Introduction
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Large Volume Parenteral (LVP) Market Size Growth Rate by Type
      • 1.4.2 Soft Bag LVP
      • 1.4.3 Plastic Bottle LVP
      • 1.4.4 Glass Bottle LVP
    • 1.5 Market by Application
      • 1.5.1 Global Large Volume Parenteral (LVP) Market Size Growth Rate by Application
      • 1.5.2 Basic Infusion
      • 1.5.3 Therapeutic Infusion
      • 1.5.4 Nutritious Infusion
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Large Volume Parenteral (LVP) Market Size
      • 2.1.1 Global Large Volume Parenteral (LVP) Revenue 2014-2025
      • 2.1.2 Global Large Volume Parenteral (LVP) Sales 2014-2025
    • 2.2 Large Volume Parenteral (LVP) Growth Rate by Regions
      • 2.2.1 Global Large Volume Parenteral (LVP) Sales by Regions
      • 2.2.2 Global Large Volume Parenteral (LVP) Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Large Volume Parenteral (LVP) Sales by Manufacturers
      • 3.1.1 Large Volume Parenteral (LVP) Sales by Manufacturers
      • 3.1.2 Large Volume Parenteral (LVP) Sales Market Share by Manufacturers
    • 3.2 Large Volume Parenteral (LVP) Revenue by Manufacturers
      • 3.2.1 Large Volume Parenteral (LVP) Revenue by Manufacturers (2014-2019)
      • 3.2.2 Large Volume Parenteral (LVP) Revenue Share by Manufacturers (2014-2019)
    • 3.3 Large Volume Parenteral (LVP) Price by Manufacturers
    • 3.4 Large Volume Parenteral (LVP) Manufacturing Base Distribution, Product Types
      • 3.4.1 Large Volume Parenteral (LVP) Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Large Volume Parenteral (LVP) Product Type
      • 3.4.3 Date of International Manufacturers Enter into Large Volume Parenteral (LVP) Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type

    • 4.1 Global Large Volume Parenteral (LVP) Sales by Type
    • 4.2 Global Large Volume Parenteral (LVP) Revenue by Type
    • 4.3 Large Volume Parenteral (LVP) Price by Type

    5 Breakdown Data by Application

    • 5.1 Overview
    • 5.2 Global Large Volume Parenteral (LVP) Breakdown Data by Application

    6 North America

    • 6.1 North America Large Volume Parenteral (LVP) by Country
      • 6.1.1 North America Large Volume Parenteral (LVP) Sales by Country
      • 6.1.2 North America Large Volume Parenteral (LVP) Revenue by Country
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Large Volume Parenteral (LVP) by Type
    • 6.3 North America Large Volume Parenteral (LVP) by Application

    7 Europe

    • 7.1 Europe Large Volume Parenteral (LVP) by Country
      • 7.1.1 Europe Large Volume Parenteral (LVP) Sales by Country
      • 7.1.2 Europe Large Volume Parenteral (LVP) Revenue by Country
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Large Volume Parenteral (LVP) by Type
    • 7.3 Europe Large Volume Parenteral (LVP) by Application

    8 Asia Pacific

    • 8.1 Asia Pacific Large Volume Parenteral (LVP) by Region
      • 8.1.1 Asia Pacific Large Volume Parenteral (LVP) Sales by Region
      • 8.1.2 Asia Pacific Large Volume Parenteral (LVP) Revenue by Region
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 South Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Thailand
      • 8.1.10 Malaysia
      • 8.1.11 Philippines
      • 8.1.12 Vietnam
    • 8.2 Asia Pacific Large Volume Parenteral (LVP) by Type
    • 8.3 Asia Pacific Large Volume Parenteral (LVP) by Application

    9 Central & South America

    • 9.1 Central & South America Large Volume Parenteral (LVP) by Country
      • 9.1.1 Central & South America Large Volume Parenteral (LVP) Sales by Country
      • 9.1.2 Central & South America Large Volume Parenteral (LVP) Revenue by Country
      • 9.1.3 Brazil
    • 9.2 Central & South America Large Volume Parenteral (LVP) by Type
    • 9.3 Central & South America Large Volume Parenteral (LVP) by Application

    10 Middle East and Africa

    • 10.1 Middle East and Africa Large Volume Parenteral (LVP) by Country
      • 10.1.1 Middle East and Africa Large Volume Parenteral (LVP) Sales by Country
      • 10.1.2 Middle East and Africa Large Volume Parenteral (LVP) Revenue by Country
      • 10.1.3 Turkey
      • 10.1.4 GCC Countries
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Large Volume Parenteral (LVP) by Type
    • 10.3 Middle East and Africa Large Volume Parenteral (LVP) by Application

    11 Company Profiles

    • 11.1 Baxter Healthcare
      • 11.1.1 Baxter Healthcare Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Baxter Healthcare Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Baxter Healthcare Large Volume Parenteral (LVP) Products Offered
      • 11.1.5 Baxter Healthcare Recent Development
    • 11.2 Kelun Pharma
      • 11.2.1 Kelun Pharma Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Kelun Pharma Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Kelun Pharma Large Volume Parenteral (LVP) Products Offered
      • 11.2.5 Kelun Pharma Recent Development
    • 11.3 B. Braun
      • 11.3.1 B. Braun Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 B. Braun Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 B. Braun Large Volume Parenteral (LVP) Products Offered
      • 11.3.5 B. Braun Recent Development
    • 11.4 Fresenius
      • 11.4.1 Fresenius Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Fresenius Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Fresenius Large Volume Parenteral (LVP) Products Offered
      • 11.4.5 Fresenius Recent Development
    • 11.5 Teva Pharmaceutical Industries
      • 11.5.1 Teva Pharmaceutical Industries Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Teva Pharmaceutical Industries Large Volume Parenteral (LVP) Products Offered
      • 11.5.5 Teva Pharmaceutical Industries Recent Development
    • 11.6 Pfizer (Hospira)
      • 11.6.1 Pfizer (Hospira) Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Pfizer (Hospira) Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Pfizer (Hospira) Large Volume Parenteral (LVP) Products Offered
      • 11.6.5 Pfizer (Hospira) Recent Development
    • 11.7 Ostuka Pharmaceutical
      • 11.7.1 Ostuka Pharmaceutical Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Ostuka Pharmaceutical Large Volume Parenteral (LVP) Products Offered
      • 11.7.5 Ostuka Pharmaceutical Recent Development
    • 11.8 CR Double-Crane
      • 11.8.1 CR Double-Crane Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 CR Double-Crane Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 CR Double-Crane Large Volume Parenteral (LVP) Products Offered
      • 11.8.5 CR Double-Crane Recent Development
    • 11.9 Pisa
      • 11.9.1 Pisa Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Pisa Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Pisa Large Volume Parenteral (LVP) Products Offered
      • 11.9.5 Pisa Recent Development
    • 11.10 Huaren
      • 11.10.1 Huaren Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Huaren Large Volume Parenteral (LVP) Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Huaren Large Volume Parenteral (LVP) Products Offered
      • 11.10.5 Huaren Recent Development
    • 11.11 Patheon
    • 11.12 Aspen Holdings
    • 11.13 Beximco Pharma
    • 11.14 Cook Pharmica
    • 11.15 Albert David
    • 11.16 PSI Ltd
    • 11.17 Ozon Pharmaceuticals
    • 11.18 BAG Healthcare
    • 11.19 BML Parenteral Drugs

    12 Future Forecast

    • 12.1 Large Volume Parenteral (LVP) Market Forecast by Regions
      • 12.1.1 Global Large Volume Parenteral (LVP) Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Large Volume Parenteral (LVP) Revenue Forecast by Regions 2019-2025
    • 12.2 Large Volume Parenteral (LVP) Market Forecast by Type
      • 12.2.1 Global Large Volume Parenteral (LVP) Sales Forecast by Type 2019-2025
      • 12.2.2 Global Large Volume Parenteral (LVP) Revenue Forecast by Type 2019-2025
    • 12.3 Large Volume Parenteral (LVP) Market Forecast by Application
    • 12.4 North America Large Volume Parenteral (LVP) Forecast
    • 12.5 Europe Large Volume Parenteral (LVP) Forecast
    • 12.6 Asia Pacific Large Volume Parenteral (LVP) Forecast
    • 12.7 Central & South America Large Volume Parenteral (LVP) Forecast
    • 12.8 Middle East and Africa Large Volume Parenteral (LVP) Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Large Volume Parenteral (LVP) Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Large volume parenterals or LVPs (sometimes called large volume injections) are aqueous solutions usually supplied in volumes of at least 100 ml with sizes of 250 ml, 500 ml, 1000 ml, 3000 ml, and 5000 ml most common. Directions usually recommend that large quantities be administered.

      Parenteral preparations are sterile, solid dosage form or pyrogen-free liquids, which contain one or more number of active ingredients boxed in single or multi dose containers. They are meant to be administered either by infusion, transplantation or injection in the body.

      Parenteral formulations are classified into small and large based on their volume. Small volume parenteral formulations are 100ml or more and can be given as single or multi dose, whereas large volume parenteral preparations are more than 100ml, intended for single use.

      The first main kind is Soft Bag LVP, it hold a comparatively larger share in global market, which accounts for about 61.37% in 2018.
      Another main kind is Glass Bottle LVP, for many companies, Glass Bottle LVP is attractive because of the market consumption need in the future. The Glass Bottle LVP share the rest 22.34% market share in 2018.
      Plastic Bottle LVP hold the rest share, which accounts for about 16.29% in 2018.From the view of region, Asia-Pacific have a larger market share in 2018 which account for 46.29%, and will witness a stable growth in following years. North America and Europe hold a market share of 25.63% and 23.99% will still play an important role which cannot be ignored. Any changes from North America and Europe might affect the development trend of Large Volume Parenteral (LVP). South America and Middle East & Africa also play important roles in global market, but it will witness the comparatively low market share within selected regions.
      The global Large Volume Parenteral (LVP) market is valued at 9759.8 million US$ in 2018 and will reach 17690 million US$ by the end of 2025, growing at a CAGR of 8.8% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Large Volume Parenteral (LVP) market based on company, product type, end user and key regions.

      This report studies the global market size of Large Volume Parenteral (LVP) in key regions like North America, Europe, China, Japan, Middle East&Africa and India, focuses on the consumption of Large Volume Parenteral (LVP) in these regions.
      This research report categorizes the global Large Volume Parenteral (LVP) market by top players/brands, region, type and end user. This report also studies the global Large Volume Parenteral (LVP) market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Baxter Healthcare
      Kelun Pharma
      B. Braun
      Fresenius
      Teva Pharmaceutical Industries
      Pfizer (Hospira)
      Ostuka Pharmaceutical
      CR Double-Crane
      Pisa
      Huaren
      Patheon
      Aspen Holdings
      Beximco Pharma
      Cook Pharmica
      Albert David
      PSI Ltd
      Ozon Pharmaceuticals
      BAG Healthcare
      BML Parenteral Drugs

      Large Volume Parenteral (LVP) market size by Type
      Soft Bag LVP
      Plastic Bottle LVP
      Glass Bottle LVP

      In 2018, Soft Bag LVP accounted for a major share of 61% in the global Large Volume Parenteral (LVP) market. And this product segment is poised to reach 15402 M Units by 2024 from 13868 M Units in 2019.

      Large Volume Parenteral (LVP) market size by Applications
      Basic Infusion
      Therapeutic Infusion
      Nutritious Infusion

      In Large Volume Parenteral (LVP) market, Therapeutic Infusion segment holds an important share in terms of application, and it is expected to reach a volume of 9596 (M Units) by 2024, at a CAGR of 1.26% during 2019 and 2024. It means that Large Volume Parenteral (LVP) will be promising in the Therapeutic Infusion field in the next couple of years.

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Australia
      Indonesia
      Thailand
      Malaysia
      Philippines
      Vietnam
      Central & South America
      Brazil
      Middle East & Africa
      Turkey
      GCC Countries
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Large Volume Parenteral (LVP) market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Large Volume Parenteral (LVP) market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Large Volume Parenteral (LVP) companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Large Volume Parenteral (LVP) submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Large Volume Parenteral (LVP) are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (M Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Large Volume Parenteral (LVP) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Large Volume Parenteral (LVP) . Industry analysis & Market Report on Large Volume Parenteral (LVP) is a syndicated market report, published as Global Large Volume Parenteral (LVP) Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Large Volume Parenteral (LVP) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,129.98
      4,694.98
      6,259.97
      3,536.79
      5,305.18
      7,073.57
      422,167.20
      633,250.80
      844,334.40
      276,980.73
      415,471.10
      553,961.46
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report